Clinical Trials of Quadrivalent Influenza Vaccine

Clinical trial NCT06824519 · RECRUITING

Trial details

NCT number: NCT06824519
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2025-05-08
Primary completion: 2025-08-05
Enrollment: 620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.